Breast cancer screening

European Journal of Cancer

Volumn 47, Issue SUPPL. 3, 2011, Pages

  Autier, Philippe ^a  

^a INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CLINICAL EXAMINATION; BREAST EXAMINATION; BREAST SELF EXAMINATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; ECHOGRAPHY; HUMAN; INCOME; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZATION; RISK REDUCTION; SENSITIVITY ANALYSIS; SOCIOECONOMICS; X RAY;

BREAST NEOPLASMS; CARCINOMA; CLINICAL TRIALS AS TOPIC; EARLY DETECTION OF CANCER; EFFICIENCY; FEMALE; HUMANS; MAMMOGRAPHY; NEOPLASM STAGING;

EID: 80053227313     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/S0959-8049(11)70157-5     Document Type: Article

References (76)

1. DB Thomas, DL Gao, RM Ray et al. Randomized trial of breast-self- examination in Shanghai: Final results JNati Cancer Inst 94 2002 1445 1457 (Pubitemid 35243743)
2. IARC H Vainio F Bianchini IARC Handbooks of Cancer Prevention. Volume 7. Breast Cancer Screening 2002 IARC Press Lyon
3. S Shapiro Evidence on screening for breast cancer from a randomized trial Cancer 39 1977 2772 2782 (Pubitemid 8130392)
4. L Tabar, G Fagerberg, SW Duffy et al. Update of the Swedish two-county program of mammographie screening for breast cancer Radiol Clin North Am 30 1992 187 210
5. P Autier, C Héry, J Haukka et al. Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening J Clin Oncol 27 2009 5919 5923
6. N Bjurstam, L Bjorneld, SW Duffy et al. The Gothenburg breast screening trial: First results on mortality, incidence, and mode of detection for women 39-49 years at randomization Cancer 80 1997 2091 2099 (Pubitemid 27506022)
7. SM Moss, H Cuckle, L Evans et al. Effect of mammographie screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial Lancet 368 2006 2053 2060 (Pubitemid 44855105)
8. L Tabar, CJ Fagerberg, A Gad et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare Lancet 1 1985 829 832
9. L Nyström, LE Rutqvist, S Wall et al. Breast cancer screening with mammography: overview of Swedish randomised trials Lancet 341 1993 973 978 (Pubitemid 23109165)
10. SA Narod On being the right size: a reappraisal of mammography trials in Canada and Sweden Lancet 349 1997 1846 (Pubitemid 27257578)
11. I Andersson, L Janzon Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographie Screening Program J Nati Cancer Inst Monogr 1997 63 67
12. LL Humphrey, US Preventive Services Task Force Screening for breast cancer: recommendations and rationale Ann Intern Med 137 2002 344 346
13. PC Gotzsche, O Olsen Is screening for breast cancer with mammography justifiable? Lancet 355 2000 129 134 (Pubitemid 30068564)
14. SW Fletcher, JG Elmore Mammographie screening for breast cancer N EnglJ Med 348 2003 1672 1680
15. L Nyström, I Andersson, N Bjurstam et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials Lancet 359 2002 909 919 (Pubitemid 34246378)
16. L Tabar, B Vitak, HH Chen et al. The Swedish Two-County Trial twenty years later Radiol Clin North Am 38 2000 625 651
17. PC Gotzsche, M Nielsen Screening for breast cancer with mammography Cochrane Database Syst Rev 4 2006 CD001877
18. R Fischer, F Houn, A Van De Griek et al. The impact of the mammography quality standards act on the availability of mammography facilities Prev Med 27 1998 697 701 (Pubitemid 28452499)
19. JM Destouet, LW Basse, MJ Yaffe, PF Butler, PA Wilcox The ACR's Mammography Accreditation Program: ten years of experience since MQSA J Am Coll Radiol 7 2005 585 594 (Pubitemid 40884529)
20. N Perry, M Breeders, C de Wolf, S Törnberg, R Holland, L von Karsa European guidelines for quality assurance in breast cancer screening and diagnosis Ann Oncol 19 2008 614 622 (Pubitemid 351461029)
21. U.S. Preventive Services Task Force Screening for Breast Cancer U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med 151 2009 716 726
22. SJ Klug, M Hetzer, M Blettner Screening for breast and cervical cancer in a large German city: participation, motivation and knowledge of risk factors Eur J Public Health 15 2005 70 77
23. Y Spyckerelle, C Kuntz, JP Giordanella, R Ancelle-Park Pratiques de la mammographie chez les femmes de 35 75 ans: étude descriptive dans la population consultant les centres d'examens de santé Bull Cancer (Paris) 89 2002 957 962 Article in French. (Pubitemid 36026636)
24. JA Colbert, EM Kaine, JA Bigby The age at which women begin mammographie screening Cancer 101 2004 1850 1859 (Pubitemid 39314749)
25. P Autier, DA Ait Ouakrim Determinants of the number of mammography units in 31 countries with significant mammography screening Br J Cancer 99 2008 1185 1190
26. NF Boyd, JM Rommens, K Vogt et al. Mammographie breast density as an intermediate phenotype for breast cancer Lancet Oncol 6 2005 798 808 (Pubitemid 41430721)
27. MT Mandelson, O Nina, PL Porter et al. Breast density as a predictor of mammographie detection: comparison of interval- and screen-detected cancers J Nati Cancer Inst 92 2000 1081 1087 (Pubitemid 30616482)
28. NHSBSP Advisory Committee on Screening for Breast Cancer in England: past and future NHSBSP Publication 2006 No 61.
29. JG Elmore, K Armstrong, CD Lehman et al. Screening for breast cancer JAMA 293 2005 1245 1256 (Pubitemid 40327910)
30. R Smith-Bindman, PW Chu, DL Miglioretti Comparison of screening mammography in the United States and the United Kingdom JAMA 290 2003 2129 2137 (Pubitemid 37432973)
31. R Smith-Bindman, R Ballard-Barbash, DL Miglioretti et al. Comparing the performance of mammography screening in the USA and the UK J Med Screen 12 2005 50 54 (Pubitemid 40445077)
32. H Joensuu, T Lehtima, K Holli Risk for distant recurrence of breast cancer detected by mammography screening or other methods JAMA 292 2004 1064 1073 (Pubitemid 39129196)
33. FD Gilliland, N Joste, PM Stauber et al. Biologic characteristics of interval and screen-detected breast cancers JNatl Cancer Inst 92 2000 743 749 (Pubitemid 30365535)
34. S Mook, LJ Van 't Veer, EJ Rutgers et al. Independent prognostic value of screen detection in invasive breast cancer JNatl Cancer Inst 103 2011 585 597
35. SA Narod, MP Dube Re: Biologic characteristics of interval and screen-detected breast cancers J Nati Cancer Inst 93 2001 151
36. BA Virnig, TM Tuttle, T Shamliyan et al. Ductal carcinoma in situ of the breast: A systematic review of incidence, treatment and outcomes J Nati Cancer Int 102 2010 170 178
37. R Sorum, S Hofvind, P Skaane et al. Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme Breast 19 2010 499 505
38. F Wärnberg, J Yuen, L Holmberg Risk of subsequent invasive breast cancer after breast carcinoma in situ Lancet 355 2000 724 725 (Pubitemid 30107633)
39. WC Black Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening J Nati Cancer Inst 92 2000 1280 1282 (Pubitemid 30660580)
40. P Zahl, J Maehlen, HG Welch The natural history of invasive breast cancers detected by screening mammography Arch Intern Med 168 2008 2311 2316
41. G Engholm, J Ferlay, N Christensen et al. NORDCAN: Cancer incidence, mortality and prevalence in the nordic countries 2008 Danish Cancer Society (www.dep-iarc.fr/nordcan.htm)
42. S Olsson, I Andersson, I Karlberg, N Bjurstam, E Frodis, S Hakansson Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme J Med Screen 7 2000 14 18 (Pubitemid 30305461)
43. C Hery, J Ferlay, M Boniol, P Autier Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations Ann Oncol 19 2008 1009 1018 (Pubitemid 351627322)
44. SW Duffy, O Agbaje, L Tabar et al. Estimates of overdiagnosis from two trials of mammographie screening for breast cancer Breast Cancer Res 7 2005 258 265 (Pubitemid 41830164)
45. E Paci, S Duffy Overdiagnosis and overtreatment in service screening Breast Cancer Res 7 2005 266 270 (Pubitemid 41830165)
46. C Biesheuvel, A Barratt, K Howard et al. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review Lancet Oncol 8 2007 1129 1138 (Pubitemid 350182969)
47. S Morrell, A Barratt, L Irwig et al. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography Cancer Causes Control 21 2010 275 282
48. SW Duffy, E Lynge, H Jonsson et al. Complexities in the estimation of overdiagnosis in breast cancer screening Br J Cancer 99 2008 1176 1178
49. KJ Jorgensen, PC Gotzsche Over diagnosis in publicly organized mammography screening programmes: systematic review of incidence trends BMJ 339 2009 b2587
50. PH Zahl, BH Strand, J Mashlen Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study BMJ 328 2004 921 924 (Pubitemid 38496981)
51. JJ Fenton, SH Taplin, PA Carney et al. Influence of computer-aided detection on performance of screening mammography NEnglJMed 356 2007 1399 1409 (Pubitemid 46556325)
52. FJ Gilbert, SM Astley, MGC Gillan et al. Single reading with computer-aide detection for screening mammography N Engl J Med 359 2008 1675 1684
53. ED Pisano, C Gatsonis, E Hendrick et al. Diagnostic performance of digital versus film mammography for breast cancer screening N Engl J Med 353 2005 1773 1783 (Pubitemid 41549889)
54. P Skaane Studies comparing screen-film mammography and full-field digital mammography in breast cancer screening: updated review Acta Radiol 50 2009 3 14
55. C Héry, J Ferlay, M Boniol, P Autier Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations Ann Oncol 19 2008 1187 1194 (Pubitemid 351796346)
56. P Autier, M Boniol, C LaVecchia et al. Disparities in breast cancer mortality trends between thirty European countries: retrospective trend analysis of WHO mortality database BMJ 341 2010 c3620
57. L Esserman, Y Shieh, I Thompson Rethinking screening for breast cancer and prostate cancer JAMA 15 2009 1685 1692
58. DA Berry, KA Cronin, SK Plevritis et al. Effect of screening and adjuvant therapy on mortality from breast cancer N Engl J Med 353 2005 1784 1792 (Pubitemid 41549890)
59. KA Cronin, EJ Feuer, LD Clarke et al. Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the CISNET breast cancer base case analysis J Nati Cancer Inst Monogr 36 2006 112 121
60. HJ de Koning, R Boer, PG Warmerdam et al. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials J Nati Cancer Inst 87 1995 1217 1223
61. SY Tan, GJ van Oortmarssen, HJ de Koning et al. The MISCAN-Fadia continuous tumor growth model for breast cancer J Nati Cancer Inst Monogr 36 2006 56 65
62. L Tabar, MF Yen, B Vitak et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening Lancet 361 2003 1405 1410 (Pubitemid 36515039)
63. SOSSEG Reduction in breast cancer mortality from the organised service screening with mammography: 2. Validation with alternative analytic methods Cancer Epidemiol Biomarkers Prev 15 2006 52 56
64. SOSSEG Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data Cancer Epidemiol Biomarkers Prev 15 2006 45 51
65. BN Hellquist, SW Duffy, S Abdsaleh et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort Cancer 117 2011 714 722
66. M Kalager, M Zelen, F Langmark, HO Adami Effect of screening mammography on breast-cancer mortality in Norway NEnglJMed 363 2010 1203 1210
67. KJ Jorgensen, PH Zahl, PC Gotzsche Breast cancer mortality in organised mammography screening in Denmark: comparative study BMJ 340 2010 cl241
68. P Autier, M Boniol, A Gavin, L Vatten Breast cancer mortality in neighbouring European countries with different level of breast screening but similar access to treatment: An analysis of WHO mortality database BMJ 2011 in press.
69. P Autier, M Boniol, R Middleton et al. Advanced breast cancer incidence following population-based mammographie screening Ann Oncol 22 2011 1726 1735
70. P Autier, M Boniol, C Héry et al. Cancer survival statistics should be viewed with caution Lancet Oncol 8 2007 1050 1052 (Pubitemid 350182962)
71. JLF Bosco, RA Silliman, SS Thwin et al. A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies J Clin Epidemiol 63 2010 64 74
72. KA Cronin, DL Weed, RJ Connor et al. Case-control studies of cancer screening: theory and practice J Nati Cancer Inst 90 1998 498 504 (Pubitemid 28182542)
73. K Sigurdsson, H Sigvaldason Effectiveness of cervical cancer screening in Iceland, 1964-2002: a study on trends in incidence and mortality and the effect of risk factors Acta Obstet Gynecol Scand 85 2006 343 349 (Pubitemid 43879222)
74. BK Edwards, E Ward, BA Kohler et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates Cancer 116 2010 544 573
75. L Bonneux Advantages and disadvantages of breast cancer screening: Time for evidence based information Ned Tijdschr Geneeskd 153 2009 A887
76. K Bouillon, N Haddy, S Delaloge et al. Long-term cardiovascular mortality after radiotherapy for breast cancer JAm Coll Cardiol 57 2011 445 452